Tebbutt, Niall C., Wilson, Kate, Forgeson, Garry, Cunningham, David, Saunders, Mark P., Stockler, Martin R., Chua, Yujo, Zalcberg, John R., Simes, R. John, Price, Timothy J., Gebski, Val J., Cummins, Michelle M., Zannino, Dianna, van Hazel, Guy A., Robinson, Bridget, Broad, Adam, Ganju, Vinod, Ackland, Stephen P.. American Society of Clinical Oncology; 2010. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

Segelov, Eva, Carrington, Christine, Emery, Jon D., Zhang, Phoebe, Cooper, Simon, O’Kane, Carmel, Wale, Janet, Hancock, Stephen J., Sulkowski, Anthony, Bashford, John, Aranda, Sanchia, Currow, David, Zalcberg, John R., Heriot, Alexander G., Mileshkin, Linda, Coutsouvelis, John, Millar, Jeremy L., Collopy, Brian T.. Wiley-Blackwell; 2021. Developing clinical indicators for oncology: the inaugural cancer care indicator set for the Australian Council on Healthcare Standards.